Review: The biological basis of antipsychotic response in schizophrenia

Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients

(2008) I. Omer Barlas et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

CATIE and CUtLASS: can we handle the truth?

(2008) Shôn Lewis et al.   BRITISH JOURNAL OF PSYCHIATRY

Dopamine receptor D3 genotype association with greater acute positive symptom remission with olanzapine therapy in predominately caucasian patients with chronic schizophrenia or schizoaffective disorder

(2008) David H. Adams et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Clozapine interacts with the glycine site of the NMDA receptor: Electrophysiological studies of dopamine neurons in the rat ventral tegmental area

(2008) Lilly Schwieler et al.   LIFE SCIENCES

Clozapine may partially compensate for task-related brain perfusion abnormalities in risperidone-resistant schizophrenia patients

(2008) V. Molina et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy—a [123I]CNS-1261 SPET study

(2008) James M. Stone et al.   PSYCHOPHARMACOLOGY

Schizophrenia: From genes to phenes to disease

(2008) Charlotte L. Allan et al.   Current Psychiatry Reports

Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting

(2007) Malin Alenius et al.   JOURNAL OF PSYCHIATRIC RESEARCH

No association between the DRD3 Ser9Gly polymorphism and schizophrenia

(2007) Ferid Fathalli et al.   SCHIZOPHRENIA RESEARCH